THERAVANCE BIOPHARMA, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.39 USD | -1.98% |
|
-1.57% | -16.46% |
| 05-13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
| 05-13 | Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 465M | - | - | - | |||
| 682B | ||||||
| 586B | ||||||
| 364B | ||||||
| 327B | ||||||
| 285B |
